Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?-Reference-Cited by-同舟云学术

Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?

Published:2021-10-19 Issue:12 Volume:21 Page:4-19
ISSN:1526-5161
Container-title:The American Journal of Bioethics
language:en
Short-container-title:The American Journal of Bioethics

Author:

Lynch Holly Fernandez¹,Caplan Arthur²,Furlong Patricia³,Bateman-House Alison²

Affiliation:

1. University of Pennsylvania

2. NYU Langone Health

3. Parent Project Muscular Dystrophy

Funder

Greenwall Foundation

Muscular Dystrophy

Publisher

Informa UK Limited

Subject

Health Policy,Issues, ethics and legal aspects

Link

https://www.tandfonline.com/doi/pdf/10.1080/15265161.2021.1974975

Reference131 articles.

1. Revisiting FDA Approval of Aducanumab

2. Optimizing the Trade-off Between Learning and Doing in a Pandemic

3. Emerging Lessons From COVID-19 for the US Clinical Research Enterprise

4. Austin, C. P. 2021. COVID’s all-hands-on-deck approach should be standard for rare diseases. The Hill, March 18, 2021. https://thehill.com/opinion/healthcare/543461-covids-all-hands-on-deck-approach-should-be-standard-for-rare-diseases.

5. Rapid publications risk the integrity of science in the era of COVID-19

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation;BMJ Global Health;2023-11

2. Emergency Regulatory Procedures, Pharmaceutical Regulatory Politics, and the Political Economy of Vaccine Regulation in the COVID-19 Pandemic;Journal of Health Politics, Policy and Law;2023-07-31

3. Ethical challenges of clinical trials with a repurposed drug in outbreaks;Medicine, Health Care and Philosophy;2023-03-07

4. Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase;International Journal of Infectious Diseases;2023-03

5. The New Role of Ethics Committees in Emergency Use of Unproven Interventions Outside Research;Collaborative Bioethics;2023